Picture of Keeps BioPharma logo

256940 Keeps BioPharma Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
TechnologyHighly SpeculativeSmall CapSucker Stock

Annual cashflow statement for Keeps BioPharma, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsARSARSAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-16,231-12,0403,4631,612-10,383
Depreciation
Amortisation
Non-Cash Items8,6056,0346985,12911,282
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-1,5674,147-5,660-4,514-20,309
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-8,380-866-57.14,808-14,921
Capital Expenditures-123-130-1,071-6,700-34,887
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-14,154-9,297-26,520-15,575-5,410
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-14,276-9,427-27,591-22,275-40,297
Financing Cash Flow Items-35.7-298-60031,649-4,910
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities28,032-3,2728,15131,92758,537
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash6,049-13,572-19,51914,6713,266